{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:34:06Z","timestamp":1790019246283,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bioorg.2019.102972","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T13:54:57Z","timestamp":1557237297000},"page":"102972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Dipyridamole inhibits \u03b1-amylase\/\u03b1-glucosidase at sub-micromolar concentrations; in-vitro, in-vivo and theoretical studies"],"prefix":"10.1016","volume":"88","author":[{"given":"Sajjad","family":"Esmaeili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarwar","family":"Azizian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Shahmoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Shahlaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Khodarahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.102972_b0005","series-title":"Global Atlas on Cardiovascular Disease Prevention and Control","author":"Mendis","year":"2011"},{"issue":"9963","key":"10.1016\/j.bioorg.2019.102972_b0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"Abubakar","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bioorg.2019.102972_b0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1474-51510200038-5","article-title":"Platelets and cardiovascular disease","volume":"1","author":"Willoughby","year":"2002","journal-title":"Eur. J. Cardiovas. Nurs."},{"issue":"941","key":"10.1016\/j.bioorg.2019.102972_b0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/pgmj.2003.007062","article-title":"Antiplatelet therapy in cardiovascular disease","volume":"80","author":"Behan","year":"2004","journal-title":"Postgrad. Med. J."},{"issue":"4","key":"10.1016\/j.bioorg.2019.102972_b0025","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2125.2011.04034.x","article-title":"Anti-platelet therapy: phosphodiesterase inhibitors","volume":"72","author":"Gresele","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2019.102972_b0030","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.bioorg.2019.102972_b0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents","volume":"109","author":"Lugnier","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.bioorg.2019.102972_b0040","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/01.RES.0000261934.56938.38","article-title":"cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling","volume":"100","author":"Houslay","year":"2007","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.bioorg.2019.102972_b0045","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.107.162511","article-title":"Phosphodiesterase type 5: expanding roles in cardiovascular regulation","volume":"101","author":"Kass","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.bioorg.2019.102972_b0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.biopha.2017.07.084","article-title":"A comprehensive review on the potential therapeutic benefits of phosphodiesterase inhibitors on cardiovascular diseases","volume":"94","author":"Shafiee-Nick","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bioorg.2019.102972_b0055","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol. Rev."},{"issue":"6\u20137","key":"10.1016\/j.bioorg.2019.102972_b0060","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.acvd.2016.02.004","article-title":"Cyclic nucleotide phosphodiesterases in heart and vessels: a therapeutic perspective","volume":"109","author":"Bobin","year":"2016","journal-title":"Arch. Cardiovas. Dis."},{"issue":"8","key":"10.1016\/j.bioorg.2019.102972_b0065","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/sj.bjp.0703725","article-title":"The effect of selective and non-selective phosphodiesterase inhibitors on allergen-and leukotriene C4-induced contractions in passively sensitized human airways","volume":"131","author":"Schmidt","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bioorg.2019.102972_b0070","first-page":"203","article-title":"Phosphodiesterase inhibitors and the cardiovascular system","volume":"7","author":"Feneck","year":"2007","journal-title":"Contin. Educ. Anaesth. Crit. Care Pain"},{"issue":"4\u20136","key":"10.1016\/j.bioorg.2019.102972_b0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.vph.2007.12.004","article-title":"Dipyridamole, cerebrovascular disease, and the vasculature","volume":"48","author":"Chakrabarti","year":"2008","journal-title":"Vasc. Pharmacol."},{"issue":"21","key":"10.1016\/j.bioorg.2019.102972_b0080","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1053\/euhj.2000.2181","article-title":"Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty","volume":"21","author":"Otsuka","year":"2000","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.bioorg.2019.102972_b0085","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00125-003-1116-6","article-title":"Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes","volume":"46","author":"Laing","year":"2003","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.bioorg.2019.102972_b0090","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","article-title":"High risk of cardiovascular disease in patients with type 1 diabetes in the UK: a cohort study using the general practice research database","volume":"29","author":"Soedamah-Muthu","year":"2006","journal-title":"Diab. Care"},{"issue":"2","key":"10.1016\/j.bioorg.2019.102972_b0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and macrovascular complications of diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin. Diab."},{"issue":"S1","key":"10.1016\/j.bioorg.2019.102972_b0100","doi-asserted-by":"crossref","first-page":"S-51","DOI":"10.1089\/dia.2012.0031","article-title":"Hypoglycemia, diabetes, and cardiovascular disease","volume":"14","author":"Snell-Bergeon","year":"2012","journal-title":"Diab. Technol. Ther."},{"issue":"21","key":"10.1016\/j.bioorg.2019.102972_b0105","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1016\/j.bmc.2010.09.003","article-title":"Fluorescent-tagged sp2-iminosugars with potent \u03b2-glucosidase inhibitory activity","volume":"18","author":"Aguilar-Moncayo","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2019.102972_b0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/bi9016457","article-title":"New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata","volume":"49","author":"Sim","year":"2009","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.bioorg.2019.102972_b0115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2125.1987.tb03194.x","article-title":"Dipyridamole: pharmacokinetics and effects on aspects of platelet function in man","volume":"24","author":"Gregov","year":"1987","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.bioorg.2019.102972_b0120","first-page":"1662","article-title":"Variability of serum drug level following a single oral dose of dipyridamole","volume":"29","author":"Segall","year":"1988","journal-title":"J. Nucl. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2019.102972_b0125","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"Association","year":"2010","journal-title":"Diab. Care"},{"issue":"6","key":"10.1016\/j.bioorg.2019.102972_b0130","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/diacare.26.6.1902","article-title":"Hypoglycemia in diabetes","volume":"26","author":"Cryer","year":"2003","journal-title":"Diab. Care"},{"issue":"3","key":"10.1016\/j.bioorg.2019.102972_b0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2337\/diaspect.24.3.171","article-title":"Drug-induced glucose alterations part 1: drug-induced hypoglycemia","volume":"24","author":"Vue","year":"2011","journal-title":"Diab. Spectr."},{"issue":"1","key":"10.1016\/j.bioorg.2019.102972_b0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/11538290-000000000-00000","article-title":"Drug-induced hypoglycaemia","volume":"34","author":"Salem","year":"2011","journal-title":"Drug Saf."},{"issue":"4","key":"10.1016\/j.bioorg.2019.102972_b0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/14740338.2012.694424","article-title":"Drug-induced hypoglycaemia in type 2 diabetes","volume":"11","author":"Inkster","year":"2012","journal-title":"Exp. Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.bioorg.2019.102972_b0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archinte.159.3.281","article-title":"Drug-induced hypoglycemic coma in 102 diabetic patients","volume":"159","author":"Ben-Ami","year":"1999","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2019.102972_b0155","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bioorg.2019.102972_b0160","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0889-8529(05)70164-X","article-title":"Dangerous and common drug interactions in patients with diabetes mellitus","volume":"29","author":"White","year":"2000","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"4","key":"10.1016\/j.bioorg.2019.102972_b0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/014572179502100404","article-title":"Pharmacy update: drug\/drug and drug\/disease interactions and diabetes","volume":"21","author":"White","year":"1995","journal-title":"Diab. Educ."},{"key":"10.1016\/j.bioorg.2019.102972_b0170","first-page":"1","article-title":"Recurrent hypoglycemia exacerbates cerebral ischemic damage in diabetic rats via enhanced post-ischemic mitochondrial dysfunction","author":"Shukla","year":"2018","journal-title":"Transl. Stroke Res."},{"issue":"4","key":"10.1016\/j.bioorg.2019.102972_b0175","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.amjms.2016.01.011","article-title":"Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes","volume":"351","author":"Chen","year":"2016","journal-title":"Am. J. Med. Sci."},{"issue":"8959","key":"10.1016\/j.bioorg.2019.102972_b0180","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(95)91988-0","article-title":"Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme","volume":"345","author":"Herings","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bioorg.2019.102972_b0185","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2147\/VHRM.S3119","article-title":"Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes","volume":"4","author":"van de Laar","year":"2008","journal-title":"Vasc. Health Risk Manage."},{"key":"10.1016\/j.bioorg.2019.102972_b0190","series-title":"Weel, Alpha-Glucosidase Inhibitors for Type 2 Diabetes Mellitus","author":"Van de Laar","year":"2005"},{"key":"10.1016\/j.bioorg.2019.102972_b0195","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bioorg.2018.09.034","article-title":"Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-\u03b3 agonists and anti-inflammatory COX-2 selective inhibitors","volume":"82","author":"Abdellatif","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2019.102972_b0200","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9343(97)00252-0","article-title":"Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study","volume":"103","author":"Hoffmann","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bioorg.2019.102972_b0205","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcha.2016.11.002","article-title":"Dipyridamole-induced adverse effects in myocardial perfusion scans: dynamic evaluation","volume":"14","author":"Lee","year":"2017","journal-title":"IJC Heart Vasc."},{"issue":"6","key":"10.1016\/j.bioorg.2019.102972_b0210","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3109\/14756366.2012.727812","article-title":"Pyrimidine-fused heterocycle derivatives as a novel class of inhibitors for \u03b1-glucosidase","volume":"28","author":"Yousefi","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102972_b0215","series-title":"The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease","author":"Aggarwal","year":"2007"},{"key":"10.1016\/j.bioorg.2019.102972_b0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.carres.2013.07.008","article-title":"Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic \u03b1-glucosidase inhibitors","volume":"380","author":"Panahi","year":"2013","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bioorg.2019.102972_b0225","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.foodchem.2016.06.078","article-title":"Degradation products of the artificial azo dye, Allura red, inhibit esterase activity of carbonic anhydrase II: a basic in vitro study on the food safety of the colorant in terms of enzyme inhibition","volume":"213","author":"Esmaeili","year":"2016","journal-title":"Food Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2019.102972_b0230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/clinchem\/8.3.215","article-title":"An o-toluidine method for body-fluid glucose determination","volume":"8","author":"Dubowski","year":"1962","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bioorg.2019.102972_b0235","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.foodchem.2014.04.106","article-title":"Inhibitory effect of morin on tyrosinase: insights from spectroscopic and molecular docking studies","volume":"163","author":"Wang","year":"2014","journal-title":"Food Chem."},{"key":"10.1016\/j.bioorg.2019.102972_b0240","first-page":"1069","article-title":"Dose conversion among different animals and healthy volunteers in pharmacological study","volume":"9","author":"Huang","year":"2004","journal-title":"Chin. J. Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.bioorg.2019.102972_b0245","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1079\/BJN20041260","article-title":"Hypoglycaemic and anorexigenic activities of an \u03b1-amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistar rats","volume":"92","author":"Tormo","year":"2004","journal-title":"Br. J. Nutr."},{"issue":"W1","key":"10.1016\/j.bioorg.2019.102972_b0250","doi-asserted-by":"crossref","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucl. Acids Res."},{"issue":"3","key":"10.1016\/j.bioorg.2019.102972_b0255","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1006\/jmbi.1996.0410","article-title":"Carbohydrate and protein-based inhibitors of porcine pancreatic \u03b1-amylase: structure analysis and comparison of their binding characteristics","volume":"260","author":"Machius","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2019.102972_b0260","unstructured":"M. Abraham, D. Van Der Spoel, E. Lindahl, B. Hess, The GROMACS development team, GROMACS user manual version 5(2) (2014)."},{"issue":"3","key":"10.1016\/j.bioorg.2019.102972_b0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00355047","article-title":"PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules","volume":"10","author":"Van Aalten","year":"1996","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2019.102972_b0270","series-title":"Intermolecular Forces","first-page":"331","article-title":"Interaction models for water in relation to protein hydration","author":"Berendsen","year":"1981"},{"issue":"2","key":"10.1016\/j.bioorg.2019.102972_b0275","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/comjnl\/6.2.163","article-title":"A rapidly convergent descent method for minimization","volume":"6","author":"Fletcher","year":"1963","journal-title":"Comput. J."},{"issue":"1","key":"10.1016\/j.bioorg.2019.102972_b0280","doi-asserted-by":"crossref","first-page":"014101","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"7","key":"10.1016\/j.bioorg.2019.102972_b0285","doi-asserted-by":"crossref","first-page":"075503","DOI":"10.1103\/PhysRevLett.90.075503","article-title":"Predicting crystal structures: the Parrinello-Rahman method revisited","volume":"90","author":"Marto\u0148\u00e1k","year":"2003","journal-title":"Phys. Rev. Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2019.102972_b0290","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2019.102972_b0295","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5 log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2019.102972_b0300","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/08927029108022142","article-title":"Generalized Verlet algorithm for efficient molecular dynamics simulations with long-range interactions","volume":"6","author":"Grubm\u00fcller","year":"1991","journal-title":"Mol. Simul."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818315153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818315153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:50:35Z","timestamp":1758613835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818315153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":60,"alternative-id":["S0045206818315153"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.102972","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dipyridamole inhibits \u03b1-amylase\/\u03b1-glucosidase at sub-micromolar concentrations; in-vitro, in-vivo and theoretical studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.102972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102972"}}